SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO is heavily discussed currently, driven by a mix of political factors and immigration-related news. Community members are highlighting potential policy impacts and contract opportunities. Sentiment is divided, with some seeing long-term value and others expressing strong ethical concerns.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is trending as traders discuss the potential for a rebound amid fluctuating weather forecasts and debate whether natural gas prices are already reflecting winter demand; the community is actively analyzing technical indicators and storage data, while considering factors like LNG exports and production levels to gauge future price movements.

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Immunome Inc

Immunome ($IMNM) is trending amid discussions about its pipeline and recent business development, including collaborations focused on antibody-drug conjugates (ADCs). Community members are weighing the potential impact of upcoming Phase 3 data and comparing it to existing treatments, while also noting new job postings and insider activity. Overall, investors are focused on Immunome's long-term prospects in the oncology space and potential for growth.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC ($FRMI) is trending due to significant volatility after its IPO and discussions around its business model centered around powering data centers with nuclear and gas energy. The community is debating the company's valuation, potential for growth, and the implications of a recently terminated funding agreement, while some highlight its connections to political figures and potential future contracts.

Anheuser-Busch InBev SA/NV operates as a holding company, which engages in the manufacture and distribution of alcoholic and non-alcoholic beverages. It operates through the following geographical segments: North America, Middle Americas, South America, EMEA, Asia Pacific, and Global Export and Holding Companies. The company was founded on August 2, 1977 and is headquartered in Leuven, Belgium.

Anheuser-Busch InBev SA/NV - ADR

Anheuser-Busch InBev

BUD is trending amid discussions about market share, marketing strategies, and potential acquisitions. Community members are debating the impact of past controversies on the brand's value, while others highlight its global presence and potential for long-term growth, as well as short-term upside. Recent news includes Wells Fargo adjusting its rating to Overweight, and Tilray acquiring eight beer and beverage brands from Anheuser-Busch InBev.

Equinox Gold Corp. is a growth-focused mining company, which engages in the exploration of gold mining properties. It operates through the following segments: Greenstone, Mesquite, Castle Mountain, Los Filos, Aurizona, Fazenda, RDM, Santa Luz, and Corporate. The company was founded by Marc Pais on March 23, 2007, and is headquartered in Vancouver, Canada.

Equinox Gold Corp

Equinox Gold is trending amid news of selling its Brazil operations to focus on North American growth. The community is discussing the potential 10%+ move, options activity indicating upside, and a C$24.00 price target announced by Stifel Nicolaus, while also mentioning its relation to gold prices and potential.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics ($KYTX) is trending due to anticipation surrounding Phase 2 data for its KYV-101 trial in stiff person syndrome, expected soon, with the community actively discussing potential positive results. Investors are weighing the risk/reward, referencing a Morgan Stanley report with an increased price target based on a favorable risk profile. Some traders note call option activity and potential early knowledge of the upcoming data release.

Based Chad

$CHAD is trending as community members highlight its strong performance and upcoming video game release, with some noting the meme's broad recognition and Coinbase executive involvement. Chatter suggests potential for significant growth, with many in the community emphasizing holding for the long term. The conversation also touches on the broader Base ecosystem and potential airdrops.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending due to ongoing discussions around its China market strategy and potential outcomes from the Hikma patent infringement case. Community members are analyzing recent company communications, particularly those addressing stakeholder questions around China's NRDL and strategic opportunities.  Additionally, some are focused on the science behind IPE and its benefits beyond triglycerides, while others speculate about potential acquisitions.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is trending amid discussions around a new share repurchase program and dividend increase, signaling confidence and returning value to shareholders. Community members are analyzing technical indicators, discussing potential breakouts, and weighing the impact of factors like share buybacks and rising cash flow. Some are also considering how increased competition from stablecoins could affect the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the company will host a conference call and...

Birchview Capital LP Takes $558,000 Position in Immunome, Inc. $IMNM

Birchview Capital LP purchased a new position in shares of Immunome, Inc. (NASDAQ:IMNM - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange...

Immunome, Inc. $IMNM Stock Holdings Decreased by Redmile Group LLC

Redmile Group LLC lowered its position in Immunome, Inc. (NASDAQ:IMNM - Free Report) by 9.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 4,872,225 shares...

Natixis Invests $2.13 Million in Immunome, Inc. $IMNM

Natixis acquired a new position in Immunome, Inc. (NASDAQ:IMNM - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The...

Immunome (NASDAQ:IMNM) Hits New 12-Month High - Here's Why

Immunome (NASDAQ:IMNM) Sets New 1-Year High - Here's What Happened...

Immunome (NASDAQ:IMNM) Reaches New 1-Year High - Time to Buy?

Immunome (NASDAQ:IMNM) Sets New 1-Year High - Should You Buy...

Immunome, Inc. (NASDAQ:IMNM) Given Average Rating of "Moderate Buy" by Brokerages

Immunome, Inc. (NASDAQ:IMNM - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eleven research firms that are presently covering the firm, Marketbeat.com...

Kennedy Capital Management LLC Purchases 94,627 Shares of Immunome, Inc. $IMNM

Kennedy Capital Management LLC grew its position in Immunome, Inc. (NASDAQ:IMNM - Free Report) by 642.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and...

Tema Etfs LLC Takes $1.07 Million Position in Immunome, Inc. $IMNM

Tema Etfs LLC acquired a new position in shares of Immunome, Inc. (NASDAQ:IMNM - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 115,431...

Immunome (NASDAQ:IMNM) Stock Price Up 9.5% - Time to Buy?

Immunome (NASDAQ:IMNM) Stock Price Up 9.5% - Still a Buy...

IMNM
Immunome Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IMNM News

IMNMImmunome Inc